Letters of proposal for NASS' 2012 research funding applications are due Feb. 6, according to a NASS news release (pdf).
The Latest
A new study published in the American Journal of Sports Medicine examined the epidemiology of concussions among high school athletes.
A new study found glucocorticoid therapy can reduce the amount of citrullination, a process that converts the protein building block arginine into citrulline, which is thought to increase inflammation, in the joints of people with rheumatoid arthritis, according to findings…
Robert W. Giering, MD, has joined the staff at Southwestern Vermont Medical Center in Bennington, Vt., according to a Bennington Banner report.
General Electric plans to discontinue its ambulatory electronic health record product, GE Centricity Advance EHR, starting June 30, according to an InformationWeek report.
Here are five thoughts on targeted injections with Dr. Michael Port of DISC Sports and Spine Center in Marina del Rey, Calif.
Bringing Laser Therapy Into a Pain Practice: Q&A With Dr. Curtis Turchin of Pivotal Health Solutions
Curtis Turchin, MA, DC, is the director of clinical sciences in the laser products division of Pivotal Health Solutions. He discusses the benefits of adding laser therapy to pain practices.
ConforMIS, a Burlington, Mass.-based medical device company focused on personalized knee replacement implants, has raised $89 million in Series E round funding with the potential to receive more in the future, according to a company news release.
This year, there were two new codes on the treatment of Dupuytren's contracture, according to an AAOS Now report.
Medical device company Haemonetics reported a third quarter net revenue of $191.2 million, an 8 percent increase over the same period last year, according to a company news release.